StockNews.AI
IQV
StockNews.AI
210 days

IQVIA to Announce Fourth-Quarter and Full-Year 2024 Results on February 6, 2025

1. IQVIA will report Q4 2024 earnings on February 6, 2025. 2. Management will host a conference call on the same day. 3. Webcast replay will be available two hours post-event. 4. IQVIA provides clinical research services globally with 88,000 employees. 5. The company focuses on patient privacy and healthcare insights.

Earnings
-0.13%Current Return
VS
+0.56%S&P 500
$205.6901/21 04:21 PM EDTEvent Start
$205.4201/22 11:07 PM EDTLatest Updated
4m saved
Insight
Article

FAQ

Why Neutral?

Earnings release typically impacts stock price but no predictions mentioned. Past releases show mixed impacts on stock price based on results.

How important is it?

Earnings results are crucial for stock performance but specifics are unknown.

Why Short Term?

Immediate impact expected post-earnings report. Similar past occurrences affected stock in the short term.

Related Companies

IQV
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) will announce its fourth-quarter and full-year 2024 financial results before the market opens on Thursday, February 6, 2025. The IQVIA management team will also host a conference call and webcast at 9:00 a.m. Eastern Time on that same day. The earnings release and accompanying financial information will be posted on the IQVIA Investor Relations website at http://ir.iqvia.com. To listen to the event and view the presentation slides via webcast, join from the IQVIA Investor Relations website at http://ir.iqvia.com. To participate in the conference call, interested parties must register in advance by clicking on this link. Following registration, participants will receive a confirmation email containing details on how to join the conference call, including the dial-in and a unique passcode and registrant ID. At the time of the live event, registered participants can connect to the call using the information provided in the confirmation email and will be placed directly into the call. A replay of the webcast will be available approximately two hours after the conclusion of the live event. To access the webcast recording, visit http://ir.iqvia.com. About IQVIA IQVIA (NYSE:IQV) is a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. IQVIA’s portfolio of solutions are powered by IQVIA Connected Intelligence™ to deliver actionable insights and services built on high-quality health data, Healthcare-grade AI™, advanced analytics, the latest technologies and extensive domain expertise. With approximately 88,000 employees in over 100 countries, including experts in healthcare, life sciences, data science, technology and operational excellence, IQVIA is dedicated to accelerating the development and commercialization of innovative medical treatments to help improve patient outcomes and population health worldwide. IQVIA is a global leader in protecting individual patient privacy. The company uses a wide variety of privacy-enhancing technologies and safeguards to protect individual privacy while generating and analyzing information on a scale that helps healthcare stakeholders identify disease patterns and correlate with the precise treatment path and therapy needed for better outcomes. IQVIA’s insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors and scientific advances, in an effort to advance their path toward cures. To learn more, visit www.iqvia.com. IQVIAFIN

Related News